OR WAIT 15 SECS
© 2021 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Some of the continuing challenges central to the management of cutaneous T-cell lymphoma (CTCL) include improving the survival and prognosis of patients, as well as helping to make proposed treatments more affordable and accessible, says Elise A. Olsen, M.D.
Related Content:
News